Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax

J Travel Med. 2018 Jan 1;25(1):10.1093/jtm/tay071. doi: 10.1093/jtm/tay071.

Authors

Kathrine R Tan¹, Jimee Hwang^{2

3}

Affiliations

¹ Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
² U.S. President's Malaria Initiative, Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
³ Global Health Group, University of California San Francisco, San Francisco, CA, USA.

No abstract available

MeSH terms

Aminoquinolines / therapeutic use*
Antimalarials / therapeutic use*
Drug Approval / statistics & numerical data*
Humans
Malaria, Vivax / drug therapy
Malaria, Vivax / prevention & control*
Plasmodium vivax
Secondary Prevention
United States
United States Food and Drug Administration

Substances

Aminoquinolines
Antimalarials
tafenoquine

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States